← Back to headlines
Eli Lilly Widens Lead in Obesity Drug Race Against Novo Nordisk
Eli Lilly's shares surged after another win against rival Novo Nordisk, further solidifying its lead in the competitive obesity drug market.
23 Feb, 17:49 — 23 Feb, 17:49
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Philippines Energy Secretary Confirms Diesel Cargo Arrival Amid Petronas Denial
just now
Philippine President Marcos Urges Unity, Warns Against Hoarding Amid Energy Crisis
just now
Marcos to decide on fuel excise tax cut or suspension by April 13
just now